A MedTech startup had multiple VC offers but needed industry-specific validation and distribution channels more than just capital.

Our Innovative Approach: Strategic Corporate Matchmaking
We bypassed traditional VCs and directly approached 5 major healthcare corporations who could benefit from the technology. We positioned the investment as “strategic R&D outsourcing” rather than pure financial investment.

The Result: Funding Plus Market Access
Secured $8M from a healthcare giant plus access to their global distribution network – far more valuable than higher VC offers. Our hack: Treat corporate partners as strategic investors rather than just funding sources.